OPKO Health, Inc. (TLV:OPK)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
616.50
-6.60 (-1.06%)
Apr 1, 2025, 4:47 PM IDT

OPKO Health Statistics

Total Valuation

OPKO Health has a market cap or net worth of ILS 4.15 billion. The enterprise value is 4.44 billion.

Market Cap 4.15B
Enterprise Value 4.44B

Important Dates

The next estimated earnings date is Thursday, May 8, 2025.

Earnings Date May 8, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -7.68%
Shares Change (QoQ) -4.66%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 253.98M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio 46.36
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -22.91
EV / Sales 1.67
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -5.85

Financial Position

The company has a current ratio of 3.43, with a Debt / Equity ratio of 0.37.

Current Ratio 3.43
Quick Ratio 2.87
Debt / Equity 0.37
Debt / EBITDA n/a
Debt / FCF -2.42
Interest Coverage -5.76

Financial Efficiency

Return on equity (ROE) is -3.86% and return on invested capital (ROIC) is -9.54%.

Return on Equity (ROE) -3.86%
Return on Assets (ROA) -8.12%
Return on Invested Capital (ROIC) -9.54%
Return on Capital Employed (ROCE) -13.63%
Revenue Per Employee 866,692
Profits Per Employee -64,684
Employee Count 2,997
Asset Turnover 0.34
Inventory Turnover 8.86

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +41.91% in the last 52 weeks. The beta is 1.71, so OPKO Health's price volatility has been higher than the market average.

Beta (5Y) 1.71
52-Week Price Change +41.91%
50-Day Moving Average 614.07
200-Day Moving Average 573.27
Relative Strength Index (RSI) 46.31
Average Volume (20 Days) 338,025

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 23.21

Income Statement

In the last 12 months, OPKO Health had revenue of ILS 2.60 billion and -193.86 million in losses. Loss per share was -0.28.

Revenue 2.60B
Gross Profit 412.66M
Operating Income -996.38M
Pretax Income -37.81M
Net Income -193.86M
EBITDA -638.79M
EBIT -996.38M
Loss Per Share -0.28
Full Income Statement

Balance Sheet

The company has 1.55 billion in cash and 1.84 billion in debt, giving a net cash position of -283.60 million.

Cash & Cash Equivalents 1.55B
Total Debt 1.84B
Net Cash -283.60M
Net Cash Per Share n/a
Equity (Book Value) 4.97B
Book Value Per Share 7.41
Working Capital 1.71B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -668.32 million and capital expenditures -91.09 million, giving a free cash flow of -759.42 million.

Operating Cash Flow -668.32M
Capital Expenditures -91.09M
Free Cash Flow -759.42M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 15.89%, with operating and profit margins of -38.36% and -7.46%.

Gross Margin 15.89%
Operating Margin -38.36%
Pretax Margin -1.46%
Profit Margin -7.46%
EBITDA Margin -24.59%
EBIT Margin -38.36%
FCF Margin n/a

Dividends & Yields

OPKO Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 7.68%
Shareholder Yield 7.68%
Earnings Yield -4.67%
FCF Yield -18.30%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

OPKO Health has an Altman Z-Score of -0.48. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.48
Piotroski F-Score n/a